Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study

OBJECTIVE: To determine the long-term safety and efficacy of repeated intrathecal (IT) administration of autologous mesenchymal stem cell-derived neural progenitors (MSC-NPs) in patients with progressive MS by evaluating subjects 2 years after treatment. METHODS: Twenty subjects were enrolled as par...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Violaine K., Stark, James W., Yang, Sophia, Zanker, Shayna, Tuddenham, John, Sadiq, Saud A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738177/
https://www.ncbi.nlm.nih.gov/pubmed/33277427
http://dx.doi.org/10.1212/NXI.0000000000000928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738177/
https://www.ncbi.nlm.nih.gov/pubmed/33277427
http://dx.doi.org/10.1212/NXI.0000000000000928

Ejemplares similares